- Home
- ELMD vs GALT Comparison
ELMD vs GALT Comparison
Compare ELMD & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | GALT |
|---|---|---|
| Founded | 1992 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.7M | 232.3M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELMD | GALT |
|---|---|---|
| Price | $28.26 | $3.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $36.00 | $8.50 |
| AVG Volume (30 Days) | 50.3K | ★ 782.9K |
| Earning Date | 02-10-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.89 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $66,218,999.00 | N/A |
| Revenue This Year | $14.63 | N/A |
| Revenue Next Year | $11.54 | N/A |
| P/E Ratio | $30.56 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $17.73 | $0.76 |
| 52 Week High | $35.56 | $7.13 |
Technical Indicators
Market Signals| Indicator | ELMD | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 33.36 |
| Support Level | $26.98 | $3.53 |
| Resistance Level | $30.47 | $7.13 |
| Average True Range (ATR) | 1.25 | 0.63 |
| MACD | -0.23 | -0.27 |
| Stochastic Oscillator | 43.59 | 10.83 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.